NCT02673372View on ClinicalTrials.gov

Geriatric Ketamine for Pain Management Study

PHASE4CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

April 30, 2016

Primary Completion Date

February 28, 2018

Study Completion Date

April 30, 2018

Conditions
Pain
Interventions
DRUG

Morphine

intravenous Morphine given at 0.1 mg/kg as intravenous infusion (10 min) with a maximum dose of 10 mg. The device is the Care Fusion Alaris PC.

DRUG

Ketamine

Ketamine administered in sub-dissociative doses 0.3 mg/kg as a intravenous infusion (10 min). The device is the Care Fusion Alaris PC.

Trial Locations (1)

11219

Maimonides Medical Center, Brooklyn

All Listed Sponsors
lead

Antonios Likourezos

OTHER

NCT02673372 - Geriatric Ketamine for Pain Management Study | Biotech Hunter | Biotech Hunter